TY - JOUR
T1 - Propionibacterium endocarditis
T2 - A case series from the International Collaboration on Endocarditis Merged Database and Prospective Cohort Study
AU - Lalani, Tahaniyat
AU - Person, Anna K.
AU - Hedayati, Susan S.
AU - Moore, Laura
AU - Murdoch, David R.
AU - Hoen, Bruno
AU - Peterson, Gail
AU - Shahbaz, Hasan
AU - Raoult, Didier
AU - Miro, Jose M.
AU - Olaison, Lars
AU - Snygg-Martin, Ulrika
AU - Suter, Fredy
AU - Spelman, Dennis
AU - Eykyn, Susannah
AU - Strahilevitz, Jacob
AU - Van Der Meer, Jan T.
AU - Verhagen, Dominique
AU - Baloch, Khaula
AU - Abrutyn, Elias
AU - Cabell, Christopher H.
N1 - Funding Information:
This study was supported in part by the National Institutes of Health (grant HL70861 (to C.H.C.)), the Tenet Healthcare Foundation (E.A.), the ‘Red Española de Investigación en Patología Infecciosa (V-2003-REDC14A-O)’ (J.M.M.); and the Funda-ción Privada Máximo Soriano Jiménez (J.M.M.).
PY - 2007
Y1 - 2007
N2 - Propionibacterium species are occasionally associated with serious systemic infections such as infective endocarditis. In this study, we examined the clinical features, complications and outcome of 15 patients with Propionibacterium endocarditis using the International Collaboration on Endocarditis Merged Database (ICE-MD) and Prospective Cohort Study (ICE-PCS), and compared the results to 28 cases previously reported in the literature. In the ICE database, 11 of 15 patients were male with a mean age of 52 y. Prosthetic valve endocarditis occurred in 13 of 15 cases and 3 patients had a history of congenital heart disease. Clinical findings included valvular vegetations (9 patients), cardiac abscesses (3 patients), congestive heart failure (2 patients), and central nervous system emboli (2 patients). Most patients were treated with β-lactam antibiotics alone or in combination for 4 to 6 weeks. 10 of the 15 patients underwent valve replacement surgery and 2 patients died. Similar findings were noted on review of the literature. The results of this paper suggest that risk factors for Propionibacterium endocarditis include male gender, presence of prosthetic valves and congenital heart disease. The clinical course is characterized by complications such as valvular dehiscence, cardiac abscesses and congestive heart failure. Treatment may require a combination of medical and surgical therapy.
AB - Propionibacterium species are occasionally associated with serious systemic infections such as infective endocarditis. In this study, we examined the clinical features, complications and outcome of 15 patients with Propionibacterium endocarditis using the International Collaboration on Endocarditis Merged Database (ICE-MD) and Prospective Cohort Study (ICE-PCS), and compared the results to 28 cases previously reported in the literature. In the ICE database, 11 of 15 patients were male with a mean age of 52 y. Prosthetic valve endocarditis occurred in 13 of 15 cases and 3 patients had a history of congenital heart disease. Clinical findings included valvular vegetations (9 patients), cardiac abscesses (3 patients), congestive heart failure (2 patients), and central nervous system emboli (2 patients). Most patients were treated with β-lactam antibiotics alone or in combination for 4 to 6 weeks. 10 of the 15 patients underwent valve replacement surgery and 2 patients died. Similar findings were noted on review of the literature. The results of this paper suggest that risk factors for Propionibacterium endocarditis include male gender, presence of prosthetic valves and congenital heart disease. The clinical course is characterized by complications such as valvular dehiscence, cardiac abscesses and congestive heart failure. Treatment may require a combination of medical and surgical therapy.
UR - http://www.scopus.com/inward/record.url?scp=34748885645&partnerID=8YFLogxK
U2 - 10.1080/00365540701367793
DO - 10.1080/00365540701367793
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 17852887
AN - SCOPUS:34748885645
SN - 0036-5548
VL - 39
SP - 840
EP - 848
JO - Scandinavian Journal of Infectious Diseases
JF - Scandinavian Journal of Infectious Diseases
IS - 10
ER -